Verdikt
Got it. Before I size the market, I need the wedge ICP. Pick the one buyer you can win in the next 90 days and the workflow you replace first.
Pitch in a sentence. Get a verdict backed by 40+ cited sources, with the kill criteria named.
Brief · 4 of 12
Verdict-in-progress
Live
TEAM
Two technical cofounders. Prior exit at Stripe (eng) and Latham (legal ops). 14 mo together.
THESIS
AI-native legal review wedges into boutique IP firms where partner time costs $400+/hr.
PROBLEM
writingParalegals lose 4 to 7 hours per NDA. Partner review adds another 90 min on average.
ICP
Verdikt
Got it. Before I size the market, I need the wedge ICP. Pick the one buyer you can win in the next 90 days and the workflow you replace first.
Boutique IP firms, 10 to 40 attorneys. Paralegals draft NDAs today, partners redline. We replace the paralegal draft.
Which ICP segments will you sell into in year one? pick up to 3
Why I'm asking: this answer changes how Verdikt frames competition and GTM for the rest of the brief.
Continue the conversation
Add names, metrics, evidence, constraints, or nuance that should shape the next question.
Captured · 4
FOUNDERS
2 founders, exit at Pacta ($42M, 2022)
THESIS
Bottom-up via NDA review, expand to MSA + DPA
MARKET SIZE
$3.1B U.S. legal ops software, 14% CAGR
COMPETITION
Ironclad, Spellbook, Harvey. Different wedges.
Recent activity
Thesis captured from founder input
Problem section started writing
Reference URLs ingested from Crunchbase
Market sizing confirmed against Gartner
A real memo, fully marked up. You'll know exactly what you get before you pay.
"The 10× claim survives benchmarking. The moat is the ingestion graph, not the model."
Build, Pivot, or Kill. Decision-grade. Never a maybe.
One sentence a partner can quote in twelve seconds. No hedges.
Problem, market, moat, risk. Each with a defensible number.
The single fact that would reverse this verdict. Named upfront, not buried.
Every claim footnoted to a tiered source. Click the number, get the filing.
Calibrated on source quality and tier mix. Not vibes.
FROM IDEA TO EVIDENCE
Three stages. From your one-sentence pitch to a memo you can defend in any room.
Brief
A loose pitch becomes testable assumptions: buyer, price, wedge, and the evidence that would change your mind.
Start a briefPitch in. Testable assumptions out.
Research
Sources are tiered, checked, and logged as the pipeline runs. The reasoning trace is auditable, not a black box.
See the methodologyTier-graded source ingestion.
Verdict
One page. The recommendation, four facts, named kill criteria, and a footnote on every claim.
See a sample verdictSourced. One page.
“The 10× claim survives benchmarking. The moat is the ingestion graph.”
Same-day delivery. Every claim cited. Refund or re-run if it's not defensible.
Four to eight calibrated questions. Voice, deck, URL, or one sentence in.
Which buyer do you win in the next 90 days?
Indie hackers shipping to their first launch.
What band would they pay in today?
Voice on a walk. A deck. A URL. One sentence in a textbox.
Triangulated from buyer language, comparable pricing, and substitute cost.
$79 – $129/ mo
When the verdict is build, you get the four-week plan, not a pep talk.
Build a Next.js page that takes an invoice URL and returns line items, client, and next payment risk.
Two or three directions ranked on signal strength. Not generic adjacency.
Side-by-side comparison. A named winner with reasoning.
Three concerns we hear on day one. Here's what we say back.
“Just another GPT wrapper?”
Five models. Five steps. A real research pipeline, not one big prompt.
Methodology“What about my data?”
Zero retention on every provider. Not logged, not trained on.
Provider clauses“What if it's wrong?”
Every verdict names what would change the call. If we miss it, refund or re-run, your choice.
AccountabilityBuyer & pain
Segment, pain, price named.
Traced sources
40+, tiered T1 to T3.
Risks first
Kill criteria stated up front.
Next experiment
Named, with a budget.
Time to artifact
Segment, pain, price named.
40+, tiered T1 to T3.
Kill criteria stated up front.
Named, with a budget.
Buyer & pain
Generic, no segment.
Traced sources
No citations.
Risks first
Reads like a disclaimer.
Next experiment
None proposed.
Time to artifact
Generic, no segment.
No citations.
Reads like a disclaimer.
None proposed.
Buyer & pain
Founder knows them cold.
Traced sources
Real links, manually gathered.
Risks first
Only if you keep the discipline.
Next experiment
Buried under spreadsheet sprawl.
Time to artifact
Founder knows them cold.
Real links, manually gathered.
Only if you keep the discipline.
Buried under spreadsheet sprawl.
Buyer & pain
Sharp, distant from operators.
Traced sources
Tier-1, well sourced.
Risks first
Listed, rarely weighted.
Next experiment
Recommends, doesn't instruct.
Time to artifact
Sharp, distant from operators.
Tier-1, well sourced.
Listed, rarely weighted.
Recommends, doesn't instruct.
Verdikt is the only row that completes the contract.
The same primary sources VCs use to underwrite term sheets, M&A diligence, and analyst reports.
40+ sources per verdict. Every claim numbered, every link live, every source tier-graded.
+ 60 MORE · UPDATED CONTINUOUSLY · SOURCE LIBRARY VERSIONED
Every partner and founder asked for the same four things: one recommendation, numbered claims, live links, and the falsifier that would change the call. So we built it.
Named testimonials appear here once the first cohort ships. Until then, the memo above stands.
Straight answers. Scope, sources, what we won't do.
Target under 1 hour. $49.99 for the first one. Refund or re-run if it's not defensible.